HMGB1 and breast cancer: The findings reported here highlight the potential of cancer-stromal fibroblast interactions to drive chemoresistance in breast cancer in part as a result of fibroblast-induced HMGB1 production and release into the tumor microenvironment with paracrine effects on neighboring cancer cells (Figure 7).